We live in curious times. Around the world there have been massive movements of people due to regional conflicts, and now we are seeing similar seismic shifts in the political landscape in response. This is going to have inevitable consequences for human health at every level. Immigrants and refugees have specific issues with nutrition and mental health in particular, while the shift toward more inward looking societies is likely to have an impact on the way that health care is delivered to the vulnerable members of our society. Of course, stroke will be a part of this equation and we must be alert to the consequences of these political and demographic shifts on stroke research, practice and outcomes. Food for thought! To focus on the here and now and consider the year ahead, the stroke program looks to be as exciting as ever. While there is no World Stroke Congress this coming year, a regional meeting will be held in Buenos Aires, reflecting the mission of the WSO to reach as many parts of the world as possible, and the incredible growth in this region in stroke research. We will shortly be meeting in Houston for the International Stroke Conference, and in May in Prague for the European Stroke Organization Congress; and later in the year at the Asia Pacific meeting, which will be held in China. These meetings reflect the enormous energy of stroke research around the globe and the remarkable advances being made in all aspects of stroke management from primary prevention through to rehabilitation.
In monitoring the burden of stroke, the classification of disease becomes particularly important. Many of you will know that stroke has been classified within the International Classification of Diseases (ICD) 10 as a component of the Circulatory Disease Section. This long-standing tradition of the WHO classification has not been to the advantage of those tying to raise the profile of stroke, and because of this there has been a concerted effort to change the classification to incorporate stroke as a component of Neurological Diseases. Bo Norrving and others had led the initiative to change the classification system, and had finally met with success, however, hopes were dashed when this decision was recently reversed with no explanation forthcoming from the WHO, and quite rightly there was a letter of protest, 1 published in the Lancet by key leaders from stroke and neurology.
We can only hope that common sense will prevail, and the decision reversed.
The importance of monitoring global stroke statistics is emphasised by our latest edition, which contains This is the beginning of 2017, and for the journal at least, a great start!
